ArticleImmunotherapy2021
Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy.
W Nathaniel Brennen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it